Optimal Treatment of Miscarriage

• Status: Completed
• Trial end date: 2018-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The main objective of the study is to determine if there is a difference in the number of women with a complete miscarriage after 10 days between expectant management versus treatment with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage before 14 weeks and a gestational sac retained in the uterus.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Region Skane
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• nonviable intrauterine pregnancy with retained gestational sac in the uterus

• the embryo if visible 5 to 35 mm without a heart beat

• vaginal bleeding

• circulatory stable

• hemoglobin at least 80 g/L

Exclusion Criteria:

• contraindications against misoprostol